Elaine Lin, MD
Pediatrician, Division of General Pediatrics; Co-Director Cerebral Palsy and Spasticity Center
Assistant Professor of Pediatrics, Harvard Medical School
Image
Elaine Lin, MD
Pediatrician, Division of General Pediatrics; Co-Director Cerebral Palsy and Spasticity Center
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
University of Chicago
2005
Chicago
IL
Medical School
University of Chicago Pritzker School of Medicine
2010
Chicago
IL
Residency
Pediatrics
New York Presbyterian - Columbia University Medical Center
2013
New York
NY
Certifications
American Board of Pediatrics (General)
Professional History
Dr. Elaine Lin attended college and medical school at University of Chicago. She completed her residency training at Columbia University/New York Presbyterian-Morgan Stanley Children's Hospital. After training, she joined the pediatric faculty at the Icahn School of Medicine at Mount Sinai where she led the development of the Pediatric Visiting Doctors and Complex Care Program and Comprehensive Neuromuscular Care Program.
Dr. Lin is an active member of the American Academy of Pediatrics, the American Academy of Cerebral Palsy and Developmental Medicine and the Academic Pediatric Association. Her interests are in developing innovative and high quality care delivery systems for children with medical complexity, including home health care and multidisciplinary programs.
Publications
Participatory learning in home health care for complex care. View Abstract
Home Health Care of Children, Adolescents and Young Adults With Complex Medical Needs: Clinical Report. View Abstract
Implementation of an EHR-Based Emergency Information Form for Children With Medical Complexity. View Abstract
Family Perceptions of Pediatric Acute Hospital Care at Home in the United States: A Qualitative Analysis. View Abstract
Home Health Care Research for Children With Disability and Medical Complexity. View Abstract
Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells. View Abstract
A Quality Improvement Project to Improve After-visit Summary Patient Instructions in a Pediatric Multidisciplinary Neuromuscular Program. View Abstract
Utilization and Patient-Reported Outcomes of Direct-to-Consumer Telemedicine During the First 6 Weeks of the COVID-19 Pandemic in the Largest Pediatric Ambulatory Network in New York State. View Abstract
Qualitative feedback from caregivers in a multidisciplinary pediatric neuromuscular clinic. View Abstract
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. View Abstract
Risk factors for 90-day readmission and prolonged length of stay after hip surgery in children with cerebral palsy. View Abstract
Disparities in Marijuana and Tobacco Smoke Incursions Among New York City Families During Early Months of the COVID-19 Pandemic. View Abstract
PediHome: Development of a Family-Reported Measure of Pediatric Home Healthcare Quality. View Abstract
Spontaneous hydrolysis and spurious metabolic properties of a-ketoglutarate esters. View Abstract
A Multidisciplinary Home Visiting Program for Children With Medical Complexity. View Abstract
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. View Abstract
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. View Abstract
KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. View Abstract
Predicting Outcomes Using the Heart Failure Survival Score in Adults with Moderate or Complex Congenital Heart Disease. View Abstract
Antiphospholipid antibodies promote tissue factor-dependent angiogenic switch and tumor progression. View Abstract
Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome. View Abstract
Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles. View Abstract